Liraglutide studies: 1,219 papers with results
Page 18 of 25
- Weekly Liraglutide for the Management of Intractable Polydipsia and Interdialytic Weight Gain in a Patient on Hemodialysis: A Case Report.
Mora-Bravo F · Cureus · 2026
Case report or series · 4 results
- Failure of GLP-1 Agonist Therapy to Improve Weight in a 3-Year-Old Patient With Tumor-Related Obesity.
Petlansky R · Case reports in pediatrics · 2025
Case report or series · 3 results
- Super response to liraglutide in people with obesity: A case report and literature review.
Gutiérrez Medina S · Endocrinologia, diabetes y nutricion · 2024
Case report or series · 1 result
- Hypersensitivity to liraglutide: A case report.
Marino-Fernández AG · Asia Pacific allergy · 2025
Case report or series · 4 results
- A diabetic patient increased premature ventricular contractions after using liraglutide: a case report.
Huang L · Frontiers in cardiovascular medicine · 2024
Case report or series · 2 results
- Maturity-onset diabetes of the young type 9 or latent autoimmune diabetes in adults: A case report and review of literature.
Zhou GH · World journal of diabetes · 2023
Case report or series · 1 result
- Treatment of an Adolescent Female With Nonalcoholic Steatohepatitis-Related Cirrhosis With Liraglutide.
Yuen C · JPGN reports · 2023
Case report or series · 2 results
- Case Report: Liraglutide for Weight Management in Beckwith-Wiedemann Syndromic Obesity.
Caputo M · Frontiers in endocrinology · 2021
Case report or series · 3 results
- Sequential Liraglutide and Setmelanotide Therapy in Bardet-Biedl Syndrome: Metabolic and Renal Outcomes in a Real-World Case Report and Literature Review.
Pasquariello T · Nephron · 2026
Case report or series · 9 results
- Successful Reversal of Tamoxifen-Associated Weight Gain and Metabolic Dysfunction with Liraglutide in a Breast Cancer Survivor: A Case Report.
Anvarbek M · Clinical medicine insights. Case reports · 2026
Case report or series · 3 results
- Treatment of obesity with liraglutide in bipolar disorder: a case report.
Cipolla S · Frontiers in psychiatry · 2026
Case report or series · 7 results
- Novel cutaneous adverse effects of the increasingly prevalent glucagon-like peptide 1 agonists.
Carson L · Skin health and disease · 2026
Case report or series · 9 results
- Weight Loss Following Liraglutide Therapy in a Patient With Smith-Magenis Syndrome: A Case Report.
Garg DK · Cureus · 2026
Case report or series · 2 results
- Liraglutide-Induced Acute Hepatocellular Injury With Positive Rechallenge: A Case Report and Literature Review.
Adi M · Clinical medicine insights. Case reports · 2026
Case report or series · 7 results
- Liraglutide Causing Pancreatitis in an Indian Obese Female: A Case Report and Review of the Literature.
Singh J · Current drug safety · 2026
Case report or series · 6 results
- Familial partial lipodystrophy type 2 associated with a novel LMNA variant (c.604G>C; p.Glu202Gln): a Colombian family case series.
Mendoza C · Frontiers in endocrinology · 2026
Case report or series · 2 results
- Diabetic ketoacidosis induced by liraglutide overdose for weight loss in a type 2 diabetes patient: A case report.
Xu H · Medicine · 2026
Case report or series · 4 results
- Suspected liraglutide (glucagon-like peptide-1 receptor agonist)-induced hyperthyroidism: A case report.
Md Sabudin SNS · Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia · 2025
Case report or series · 11 results
- Improving the Quality of Two Lives by Treating Obesity.
Nagy N · Reports (MDPI) · 2025
Case report or series · 3 results
- Liraglutide for the Treatment of Severe Hypoglycemia Following Total Pancreatectomy and Islet Autotransplantation.
Chan C · JCEM case reports · 2024
Case report or series · 1 result
- Comparable liraglutide pharmacokinetics in pediatric and adult populations with type 2 diabetes: a population pharmacokinetic analysis.
Petri KC · Clinical pharmacokinetics · 2015
Other design · 3 results
- Allelic variant in the glucagon-like peptide 1 receptor gene associated with greater effect of liraglutide and exenatide on gastric emptying: A pilot pharmacogenetics study.
Chedid V · Neurogastroenterology and motility · 2018
Other design · 7 results
- Pharmacodynamics of NN2211, a novel long acting GLP-1 derivative.
Agersø H · European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2003
Other design · 1 result
- Population pharmacokinetics of liraglutide, a once-daily human glucagon-like peptide-1 analog, in healthy volunteers and subjects with type 2 diabetes, and comparison to twice-daily exenatide.
Watson E · Journal of clinical pharmacology · 2010
Other design · 5 results
- Liraglutide pharmacokinetics and exposure-response in adolescents with obesity.
Carlsson Petri KC · Pediatric obesity · 2021
Other design · 5 results
- Insights from changes in NDEV biomarkers of metabolism: effects of PPARγ and GLP1 receptor agonists on brain metabolism.
Evers A · The Journal of clinical endocrinology and metabolism · 2026
Other design · 6 results
- Effects of liraglutide and ischemic postconditioning on myocardial salvage after I/R injury in pigs.
Ekström K · Scandinavian cardiovascular journal : SCJ · 2017
Animal study (in vivo) · pig · 3 results
- Comparative Study of Liraglutide and Insulin Glargine on Glycemic Control and Pancreatic β-Cell Function in db/db Mice.
Li Y · Medical science monitor : international medical journal of experimental and clinical research · 2018
Animal study (in vivo) · mouse · 9 results
- Comparative study on anorexigenic effect of glucagon-like peptide-1 receptor agonists in rats.
Wen S · Sheng li xue bao : [Acta physiologica Sinica] · 2019
Animal study (in vivo) · rat · 4 results
- The novel GLP-1/GIP dual agonist DA3-CH is more effective than liraglutide in reducing endoplasmic reticulum stress in diabetic rats with cerebral ischemia-reperfusion injury.
Bai B · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2021
Animal study (in vivo) · rat · 8 results
- Characterization of the use of liraglutide for glycemic control in healthy and Type 1 diabetes mellitus suffering dogs.
Oda H · Research in veterinary science · 2013
Animal study (in vivo) · dog · 4 results
- Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis.
Hunter K · BMC neuroscience · 2012
Animal study (in vivo) · 8 results
- Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.
Kanoski SE · Endocrinology · 2011
Animal study (in vivo) · rat · 6 results
- The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide.
Kanoski SE · Neuropharmacology · 2012
Animal study (in vivo) · rodents · 15 results
- Topical Administration of GLP-1 Receptor Agonists Prevents Retinal Neurodegeneration in Experimental Diabetes.
Hernández C · Diabetes · 2016
Animal study (in vivo) · mouse · 7 results
- Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
Liu W · Neuroscience · 2015
Animal study (in vivo) · mouse · 10 results
- GLP-1 derivative liraglutide in rats with beta-cell deficiencies: influence of metabolic state on beta-cell mass dynamics.
Sturis J · British journal of pharmacology · 2003
Animal study (in vivo) · rat · 12 results
- Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease.
McClean PL · Neuropharmacology · 2014
Animal study (in vivo) · mouse · 16 results
- Semaglutide is Neuroprotective and Reduces α-Synuclein Levels in the Chronic MPTP Mouse Model of Parkinson's Disease.
Zhang L · Journal of Parkinson's disease · 2019
Animal study (in vivo) · mouse · 16 results
- Liraglutide Modulates Appetite and Body Weight Through Glucagon-Like Peptide 1 Receptor-Expressing Glutamatergic Neurons.
Adams JM · Diabetes · 2018
Animal study (in vivo) · mouse · 5 results
- Structural modulation of the gut microbiota and the relationship with body weight: compared evaluation of liraglutide and saxagliptin treatment.
Wang L · Scientific reports · 2016
Animal study (in vivo) · mouse · 5 results
- Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
Tølbøl KS · World journal of gastroenterology · 2018
Animal study (in vivo) · mouse · 9 results
- The GLP-1 analogue lixisenatide decreases atherosclerosis in insulin-resistant mice by modulating macrophage phenotype.
Vinué Á · Diabetologia · 2017
Animal study (in vivo) · mouse · 18 results
- Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats.
Hayes MR · Obesity (Silver Spring, Md.) · 2011
Animal study (in vivo) · rat · 13 results
- The autonomic nervous system and cardiac GLP-1 receptors control heart rate in mice.
Baggio LL · Molecular metabolism · 2017
Animal study (in vivo) · mouse · 8 results
- The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson's Disease.
Zhang L · Journal of Parkinson's disease · 2020
Animal study (in vivo) · mouse · 6 results
- Neuroprotection in Rats Following Ischaemia-Reperfusion Injury by GLP-1 Analogues-Liraglutide and Semaglutide.
Basalay MV · Cardiovascular drugs and therapy · 2019
Animal study (in vivo) · rat · 8 results
- The human GLP-1 analogs liraglutide and semaglutide: absence of histopathological effects on the pancreas in nonhuman primates.
Gotfredsen CF · Diabetes · 2014
Animal study (in vivo) · cynomolgus monkey · 11 results
- Sitagliptin and Liraglutide Modulate L-dopa Effect and Attenuate Dyskinetic Movements in Rotenone-Lesioned Rats.
Badawi GA · Neurotoxicity research · 2019
Animal study (in vivo) · rat · 7 results
- Novel GLP-1/GLP-2 co-agonists display marked effects on gut volume and improves glycemic control in mice.
Wismann P · Physiology & behavior · 2018
Animal study (in vivo) · mouse · 5 results